Balance Labs, Inc. (BLNC)

AI-Powered SEC Filing Analysis

Quarterly Report Filed: 2026-05-15

Key Insights

  • Balance Labs shows significant related-party transaction activity with Michael Farkas and The Farkas Group Inc, including multiple notes payable and short-term advances, indicating potential cash flow dependency on insider financing rather than operational cash generation.
  • The company maintains convertible debt instruments (Chase Mortgage Convertible Notes and CEO convertible notes) with fair value measurements across multiple levels, suggesting potential dilution risk to existing shareholders upon conversion.
  • Subsequent events through May 11, 2026 show continued transactions with The Farkas Group Inc, indicating ongoing related-party dealings that may raise corporate governance concerns and require close monitoring of insider influence on company operations.
  • The filing structure shows multiple categories of notes payable from various related parties (CEO loans, Foundation, Balance Group LLC, pre-conversion agreements), suggesting a complex capital structure with potential refinancing and repayment obligations that could strain liquidity.
Filing tone (AI): Negative
View Original Filing →
Annual Report Filed: 2026-04-10

Key Insights

  • Balance Labs, Inc. (BLNC) reported steady revenue growth over the past three fiscal years, indicating a stable business model.
  • The company has been relying on related party loans and notes payable to finance its operations, which raises concerns about its long-term financial sustainability.
  • The company's CEO and president have recently taken on increased compensation and equity awards, which could potentially conflict with shareholder interests.
Filing tone (AI): Neutral
View Original Filing →
Current Report Filed: 2026-02-11

Key Insights

  • Balance Labs, Inc. has appointed a new President and Chief Operating Officer, Alexander Farkas, who brings experience in energy systems, early-stage investing, and digital assets, which aligns with the company's mission.
  • The compensation package for the new President and COO includes a base salary of $120,000, a target bonus of 65% of base salary, and the ability to receive the bonus in the company's common stock.
  • The employment agreement with the new President and COO has an initial two-year term with automatic renewal, and provisions for termination, including severance payments in the event of termination without cause or resignation for good reason.
Filing tone (AI): Positive
View Original Filing →

Filings on this page are at least 90 days old. In the app, any new Balance Labs, Inc. filing is analysed the moment you open it.

Download on theApp Store Get it onGoogle Play

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.